Hydralazine as antihypertensive therapy in obesity-related hypertension


OBJECTIVE: The objectives were two-fold: (1) determine whether the use of hydralazine as antihypertensive therapy during obesity development exacerbated obesity-related cardioacceleration and hormonal abnormalities; (2) determine whether the absence of hypertension in obesity attenuated obesity-related abnormalities in hemodynamics, cardiac hypertrophy, and… (More)
DOI: 10.1038/sj.ijo.0802573


5 Figures and Tables